reference/6144321

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6144321

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	244
issn	1550-9397 1550-9389
issueIdentifier	1
pageRange	235-244
publicationName	Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
startingPage	235
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_853cae02dba8e490584eada3f64d2b35 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b59273bbd3bb854695c1f221a3cef6f3 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ee9f7e81a68de5442a5239c52d3bf5c9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8addf55a7d2bea837429435c7e54470f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bbf4e126648a9daafa5415bf69a21c5c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_11410b184f59d83279c5b64cb0df82ba
bibliographicCitation	Rosenberg R, Thorpy MJ, Dauvilliers Y, Schweitzer PK, Zammit G, Gotfried M, Bujanover S, Scheckner B, Malhotra A. Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy. Journal of Clinical Sleep Medicine. 2022 Jan;18(1):235–44. doi: 10.5664/jcsm.9550.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed6316e53c23b4be1c86bf9b1077f9af http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5775522eaab254acba56dd2219d0eccc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c66994ae4ccad4e8303bb29e19ca5532 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b410601e7431c1d74e61480d5b47017d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9505b48e65214e9d1e2f2cefc506707c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c57506b045bb41c97ce2c8b8f240cc7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8efc09d7689596fbb62e3bcde7886e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd485bb5821ccf33f417f3db0bf272f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78c4e6c1927fe34a026ee372e7864907
date	2022-01-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8807921 https://doi.org/10.5664/jcsm.9550 https://pubmed.ncbi.nlm.nih.gov/34283019
isPartOf	https://portal.issn.org/resource/ISSN/1550-9397 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32554 https://portal.issn.org/resource/ISSN/1550-9389
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy
discusses	http://id.nlm.nih.gov/mesh/M000637168 http://id.nlm.nih.gov/mesh/M0003327 http://id.nlm.nih.gov/mesh/M0016544
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D020181Q000453 http://id.nlm.nih.gov/mesh/D006970 http://id.nlm.nih.gov/mesh/D009290Q000188 http://id.nlm.nih.gov/mesh/D020181Q000150 http://id.nlm.nih.gov/mesh/D009290Q000453 http://id.nlm.nih.gov/mesh/D009290Q000150 http://id.nlm.nih.gov/mesh/D020181Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D010649Q000031 http://id.nlm.nih.gov/mesh/D015994 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D016032 http://id.nlm.nih.gov/mesh/D002219 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6910 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6923 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c9a6abbfbceb6093666385f4bb3af227 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10130337 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10463 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8177 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9653 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8099 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8587 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593

Showing number of triples: 1 to 64 of 64.